Capricor Therapeutics Total Assets 2006-2019 | CAPR

Capricor Therapeutics total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Capricor Therapeutics Annual Total Assets
(Millions of US $)
2018 $9
2017 $16
2016 $19
2015 $16
2014 $14
2013 $6
2012 $5
2011 $1
2010 $4
2009 $4
2008 $6
2007 $17
2006 $0
2005 $0
Capricor Therapeutics Quarterly Total Assets
(Millions of US $)
Q1 2019 $9
Q4 2018 $9
Q3 2018 $12
Q2 2018 $14
Q1 2018 $15
Q4 2017 $16
Q3 2017 $16
Q2 2017 $14
Q1 2017 $14
Q4 2016 $19
Q3 2016 $24
Q2 2016 $14
Q1 2016 $17
Q4 2015 $16
Q3 2015 $20
Q2 2015 $24
Q1 2015 $27
Q4 2014 $14
Q3 2014 $16
Q2 2014 $18
Q1 2014 $16
Q4 2013 $6
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $5
Q3 2012 $0
Q2 2012 $1
Q1 2012 $1
Q4 2011 $1
Q3 2011 $3
Q2 2011 $4
Q1 2011 $2
Q4 2010 $4
Q3 2010 $5
Q2 2010 $6
Q1 2010 $2
Q4 2009 $4
Q3 2009 $5
Q2 2009 $2
Q1 2009 $4
Q4 2008 $6
Q3 2008 $8
Q2 2008 $11
Q1 2008 $14
Q4 2007 $17
Q3 2007 $19
Q2 2007 $0
Q1 2007 $0
Q4 2006 $0
Q3 2006 $0
Q2 2006 $0
Q1 2006 $0
Q4 2005 $0
Q3 2005 $0
Q2 2005 $0
Q1 2005 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.017B $0.002B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $155.371B 29.26
Medtronic (MDT) Ireland $135.779B 19.40
Stryker (SYK) United States $77.789B 27.76
Boston Scientific (BSX) United States $59.103B 28.33
Baxter (BAX) United States $42.186B 26.59
EssilorLuxottica Societe Anonyme (ESLOY) France $29.208B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.885B 0.00
Coloplast (CLPBY) Denmark $25.726B 41.07
Zimmer Biomet Holdings (ZBH) United States $25.151B 16.16
Terumo (TRUMY) Japan $21.510B 24.73
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
ResMed (RMD) United States $17.729B 33.87
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.051B 0.00
Bio-Rad Laboratories (BIO) United States $9.286B 49.23
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.213B 525.52
Perrigo (PRGO) Ireland $7.110B 12.02
Hill-Rom Holdings (HRC) United States $6.994B 21.20
Aurora Cannabis (ACB) Canada $6.825B 67.30
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.276B 51.23
ICU Medical (ICUI) United States $5.165B 30.82
GW Pharmaceuticals (GWPH) United Kingdom $4.920B 0.00
Neogen (NEOG) United States $3.306B 53.75
NuVasive (NUVA) United States $3.038B 24.81
Agios Pharmaceuticals (AGIO) United States $2.771B 0.00
Hutchison China MediTech (HCM) China $2.690B 0.00
National Vision Holdings (EYE) United States $2.444B 52.08
Quidel (QDEL) United States $2.233B 23.17
Cardiovascular Systems (CSII) United States $1.553B 891.80
Aphria (APHA) $1.549B 0.00
AtriCure (ATRC) United States $1.223B 0.00
Phibro Animal Health (PAHC) United States $1.210B 18.13
VAREX IMAGING (VREX) United States $1.182B 25.08
NanoString Technologies (NSTG) United States $1.115B 0.00
Lantheus Holdings (LNTH) United States $1.074B 28.53
PetIQ (PETQ) United States $1.006B 24.43
Quanterix (QTRX) United States $0.782B 0.00
Cerus (CERS) United States $0.777B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.34
Omeros (OMER) United States $0.714B 0.00
MacroGenics (MGNX) United States $0.707B 0.00
TG Therapeutics (TGTX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.620B 30.03
Surmodics (SRDX) United States $0.521B 75.80
OraSure Technologies (OSUR) United States $0.520B 23.94
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.515B 0.00
Meridian Bioscience (VIVO) United States $0.489B 14.96
BioLife Solutions (BLFS) United States $0.354B 110.71
Utah Medical Products (UTMD) United States $0.325B 22.51
Vapotherm (VAPO) United States $0.312B 0.00
Zynex (ZYXI) United States $0.255B 26.23
Cytosorbents (CTSO) United States $0.236B 0.00
Bovie Medical (APYX) United States $0.226B 0.00
Chimerix (CMRX) United States $0.185B 0.00
Rockwell Medical (RMTI) United States $0.171B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.155B 3.29
Fonar (FONR) United States $0.139B 7.31
Female Health (VERU) United States $0.135B 0.00
Chembio Diagnostics (CEMI) United States $0.105B 0.00
United-Guardian (UG) United States $0.093B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.065B 0.00
MRI INTERVENTNS (MRIC) United States $0.053B 0.00
Trinity Biotech (TRIB) Ireland $0.051B 17.58
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00